ABSTRACT 12-0-Tetradecanoylphorbol 13-acetate (TPA), a powerful tumor promoter, is shown to induce sister chromatid exchanges (SCEs), whereas the nonpromoting derivative 4-0-methyl-TPA does not. Inhibitors of tumor promotion-antipain, leupeptin, and fluocinolone acetonide-inhibit formation of such TPA-induced SCEs.
such TPA-induced SCEs. TPA is a unique agent in its induction of SCEs in the absence of DNA damage, chromosome aberrations, mutagenesis, or significant toxicity. Because TPA is known to induce several gene functions, we speculate that it might also induce enzymes involved in genetic recombination. Thus, the irreversible step in tumor promotion might be the result of an aberrant mitotic segregation event leading to the expression of carcinogen/mutagen-induced recessive genetic or epigenetic chromosomal changes. Carcinogenesis is usually a multistep process. Epidemiological studies of human carcinomas indicate that several distinct heritable changes are necessary to change a normal cell into a malignant cell (1) . This stepwise process is best illustrated in the two-stage mouse skin carcinogenesis system, which is composed of "initiation" and "promotion" stages (2, 3) . Initiators, such as radiation or chemical carcinogens, cause rapid irreversible changes, mutagenic or epigenetic in origin, which result in a "premalignant" state that is inherited by both daughters when "initiated" cells divide. Promoters are neither significantly carcinogenic (3) or mutagenic (4, 5) when tested alone, but greatly increase tumor frequency and shorten the lag time for tumor appearance when added after an initiator. Thus, tumor promoters complete a process begun by initiators.
These facts prompted us to consider the possibility that initiated cells contain specific recessive, autosomal, somatic mutations and that promotion causes the expression of these mutations by inducing an aberrant mitotic segregation event. The initiated heterozygous cell is thus converted into a homozygous or hemizygous cell (see Fig. 1 and legend) . This would be consistent with the finding that the nonviral malignant (or transformed) phenotype is usually suppressed on hybridization with nontransformed cells and that malignant segregants can reappear as a result of chromosome loss (7, 8) . Although the term "recessive mutation" is used throughout this paper, our hypothesis is compatible with any model of initiation based upon stable, recessive, genetic, or epigenetic chromosomal changes.
Aneuploidy and aberrant mitotic segregations have already been postulated as a prerequisite for malignant transformation (1, 9) . This speculation was applied specifically to tumor promotion (6) , and a preliminary study has shown that a nontoxic dose of the tumor promoter 12-0-tetradecanoylphorbol 13-acetate (TPA) induces the segregation of two recessive traits, 6-thioguanine resistance and growth on agar, from doubly heterozygous cell hybrids (10).
Six possible mechanisms for the segregation of a recessive mutation from a heterozygous cell are presented in Fig. 1. (i) Chromosomal rearrangement or deletion and (ii) one-step nondisjunction both lead to hemizygosity, while (iii) two-step nondisjunction, (iv) aberrant mitotic segregation (in the absence of nondisjunction or mitotic recombination), (v) increase in ploidy plus chromosome loss, and (vi) mitotic recombination all lead to homozygosity. Only the events leading to homozygosity (iii-vi) are consistent with the observation that initiation must precede promotion in order to produce an enhanced carcinogenic effect. Furthermore, mechanisms i and ii are made unlikely by the fact that chromosome loss or deletion is usually lethal to normal diploid cells (11) .
We present here a cytological study of the effects of TPA on Chinese hamster cells in culture to test the hypothesis of tumor promotion outlined in Fig. 1 . This study was encouraged by the demonstration of promotion processes in cell culture (ref. 12 and references therein) and by the observation that griseofulvin, a known promoter of dimethylbenzanthracene-initiated mouse skin tumors (13) , induces high ploidy and subsequent chromosome loss in cell cultures (14) , which would be consistent with mechanism v listed above. isolated by "mitotic shake-off." Metaphase preparations and differential staining were essentially as described by Perry and Wolff (15) . All visible metaphases were analyzed for SCEs. Because promoting activity of TPA is correlated with skin irritation and inflammation (3), the activity of the agents used Abbreviations: SCE, sister chromatid exchange; TPA, 12-0-tetradecanoylphorbol 13 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. in this study was tested by spotting 10 ,l of 10 Ag/ml solutions in acetone onto the ears of BALB/c mice. TPA spots caused inflammation within 12 hr, while 4-0-Me-TPA and acetone alone did not.
MATERIALS AND METHODS

RESULTS
To test the hypothesis presented in Fig. 1 , the effects of TPA on ploidy, chromosome loss, chromosomal aberrations, and SCEs have been studied. Only an increase in SCE frequency was observed (Fig. 2 A, B , and C). In addition to the approximately 2-fold increase in countable SCEs seen in the majority of the cells,* up to 25% of the TPA-treated cells showed SCEs that were "too many to count" (more than 100 SCEs per metaphase) (Fig. 2C) . This "two-population effect" was also observed with two independent V79 clones derived from our cultures, thus eliminating the involvement of stable mixed cell populations (results not shown).
TPA toxicity was seen to vary between batches, but in general the maximum induction of SCEs was found in the absence of major toxicity as measured by cloning efficiency (Table 1) and growth curves (Fig. 3) . The optimum SCE induction occurred at 1.6 ,gM (1 ,g/ml) TPA (Table 2) ; TPA at 5 ,gg/ml was lethal without causing further increase in SCEs (Table 2) .
In an attempt to correlate SCE induction with mouse skin tumor promotion, 4-0-Me-TPA, a nonpromoting derivative (16) , was found to have no effect on SCEs (Fig. 4) Table 2 ). (D) TPA-treated metaphase with "banded" chromosomes discussed in the text.
* Because TPA induction of SCEs is independent of BrdUrd concentration (see (18) . Fifty to 80% inhibition of TPA-induced SCEs was seen in the presence of 1 mM concentrations of either antipain or leupeptin (Table  2) . Antipain was seen to inhibit the "too many to count" class of TPA-treated metaphases (Fig. 5 , Table 2 ). The simultaneous presence of both inhibitors did not seem to enhance the inhibitory effect (Table 2 , entry II). FA (2.7 jM) gave 100% inhibition of TPA SCE induction and at the doses usedt appears to be the most effective inhibitor. In addition to SCEs, the only noticeable effects of TPA on V79 chromosomes were the appearance of "banded" chromosomes (Fig. 2D ) (which were not seen in control metaphases and whose appearance was inhibited by antipain but not by FA) and an increase in unlabeled metaphases (Table 2) , the latter indicating an inhibition of DNA replication. A transitory inhibition of DNA synthesis by TPA has been seen both on mouse skin and in cell culture systems (for a review see ref. 19 ).
DISCUSSION
The most striking chromosomal effect of TPA on V79 cells in culture is an increased frequency of SCEs ( Fig. 2 B and C) . The appearance of banded chromosomes (Fig. 2D) in TPA-treated cells may be tentatively interpreted either as being due to a partial, discontinuous incorporation of BrdUrd because of the inhibition of DNA elongation in many chromosomal replicons or as a visualization of TPA-induced structural changes in the chromatin (e.g., proteolytic removal of some components of the chromatin).
Three observations implicate TPA as a unique inducer of SCEs: (i) other SCE-inducing compounds cause damage to DNA (20) (21) (22) , whereas TPA does not (3, 23) ; (ii) the increase in the SCE frequency even in the "too many to count" class occurs in the absence of a detectable increase in chromosome aberrations normally seen with other SCE-inducing agents; (iii) unlike other SCE-inducing agents, TPA at effective concentrations is nontoxic (Fig. 3) and nonmutagenic for V79 cells (4, 5) . The increase in SCEs after treatment with TPA is not related to cellular toxicity effects: 4-O-Me-TPA is at least as toxic as TPA (Table 1) , high doses of TPA are less effective SCE inducers than nontoxic doses ( toxicity (not shown; see also labeled metaphases in Table 2 ). These observations, together with the fact that TPA is known to induce transiently several cellular changes and specific enzymes (3, 19, 24) , have led us to postulate that TPA-provoked SCE induction might result from the induction of cellular DNA recombination enzymes.
The lack of SCE induction by the nonpromoting derivative 4-O-Me-TPA (Fig. 4) and the inhibition of SCE induction by two known classes of inhibitors of tumor promotion (Table 2 ) strongly implicate the role of SCE-type recombinogenic activity in tumor promotion. The SCE-inducing effect of TPA can be Appropriate concentrations of the inhibitors were added simultaneously with TPA and the cultures were incubated for 27 hr. Antipain and leupeptin stock solutions were in water and TPA and FA in acetone; the controls were adjusted accordingly. The concentrations of inhibitors used were nontoxic and did not themselves induce SCEs. About 10 independent replicate experiments were performed, and all showed similar SCE-inducing effects of TPA. *No absolute distinction could be made between "too many to count" and banded chromosomes.
related to the mitotic recombination mechanism in the hypothesis of promotion in Fig. 1 only by assuming that SCE frequency can be considered as a cytological indication of cellular recombinogenic activity (20, 22, 25) , particularly in the absence of DNA damage. All attempts to detect mitotic recombination in mammalian cells by using genetic markers have so far failed (26, 27) , indicating that, if it occurs, mitotic recombination must be very rare. However, cytological evidence shows that quadriradial chromosomes, although rare, represent exchanges between both sister and nonsister homologous chromatids (25, 28) . Increased frequency of quadriradial chromosomes has been observed only in cells containing very high levels of either spontaneous (28) or induced (ref. 25 ; unpublished data) SCEs. Hence, the assumption that SCEs reflect cellular recombinational activity seems reasonable, although no quantitative relationship between either the absolute frequency or the increase in frequency of SCEs and mitotic recombination frequency can be established.
Bloom's syndrome, the striking human cancer-prone hereditary disease, provides circumstantial evidence favoring our hypothesis, because cells taken from these patients are characterized by very high levels of spontaneous SCEs and of quadriradial chromosomes (28) . Thus, we propose that Bloom's syndrome may be caused by a mutation resulting in a promotion-constitutive phenotype.
The fact that radiation and chemical mutagens not only are initiators but also are carcinogenic at high doses would be consistent with our specific hypothesis of "two-stage" carcinogenesis, because high doses of initiators are known to induce both mutagenesis and SCEs in mammalian cells (20) (21) (22) expression (3, 4, 19, 32) or induction of enzymes required for mutation fixation (33) , are not necessarily in contradiction with our hypothesis; several events might be, required to accomplish tumor promotion (3) , and these may reflect qualitatively different processes.
